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Abstract
Cancer fatalism is believed to be a major barrier for cancer screening in Black males. Therefore,
the purpose of this study was to compare perceptions of prostate cancer (CaP) fatalism and
predictors of CaP screening with Prostate Specific Antigen (PSA) testing between U.S.-born and
Caribbean-born Black males. The Powe Fatalism Inventory and the Personal Integrative Model of
CaP Disparity Survey were used to collect the following data from males in South Florida.
Multivariate logistic regression models were constructed to examine the statistically significant
predictors of CaP screening. A total of 211 U.S.-born and Caribbean-born Black males between
ages 39–75 were recruited. Nativity was not a significant predictor of CaP screening with PSA
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testing within the last year (Odds ratio [OR] = 0.80, 95 % confidence interval [CI] = 0.26, 2.48, p
= 0.70). Overall, higher levels of CaP fatalism were not a significant predictor of CaP screening
with PSA testing within the last year (OR = 1.37, 95 % CI = 0.48, 3.91, p = 0.56). The study
results suggest that nativity did not influence CaP screening with PSA testing. However, further
studies are needed to evaluate the association between CaP screening behavior and levels of CaP
fatalism.
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Background
In 2012, an estimated 241,740 new cases of prostate cancer (CaP) were diagnosed among all
males in the United States [1]. When compared to Caucasian males, Black males were more
likely to be diagnosed with extraprostatic disease or to have tumors metastasized to distant
lymph nodes [2]. The United States death rate for CaP was 2.4 times higher in Black males
than in Caucasian males [3].
The causes of the racial differentials in CaP incidence and mortality between Black and
Caucasian males are varied. Researchers have claimed that these differences reflect social
and economic disparities rather than biological differences associated with race [3]. Factors
contributing to the social and economic disparities include: inequalities in employment,
wealth, income, education, housing, overall standards of living, barriers to high-quality
health care, and racial discrimination [3]. Further, the recent controversy in CaP screening
recommendation may continue to impact the incidence and mortality of CaP for Black males
[4-9] although, the results of the two largest randomized controlled trials of CaP screening
found conflicting results in the reduction of prostate cancer mortality [9-12].
Cancer Fatalism and Prostate Cancer Prevention Behavior
In exploring perceptions of CaP screening among Blacks, Allen and colleagues discerned
that Black males perceive cancer as a death sentence and hospitals as places where you go to
die [13]. This perception can be described as cancer fatalism. Cancer fatalism is the belief
that death is inevitable following a diagnosis of cancer, and is a major barrier to cancer
detection and control [14].
In philosophical analysis of cancer fatalism among Blacks, it was proposed that cancer
fatalism results from complex psychological cycles characterized by perceptions of:
hopelessness, worthlessness, powerless, and social despair [14]. Further, many social
economic factors can also impact the development of cancer fatalism, including: poverty,
lack of knowledge about the disease process, fear of hospitals, distrust towards health care
providers, and a fear of being used as a guinea pig [14]. Memories of incidents including the
Tuskegee Syphilis Experiment undoubtedly add to the sense of fear and mistrust of
traditional health care that persists among many Black males [15]. However, poverty,
racism, discrimination, unemployment, and inadequate access to healthcare maybe factors
that support the fundamental assumptions underlying fatalistic attitudes towards cancer [14].
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Further, the universal experience of angst and nihilism are two other distinct philosophical
factors that might actually converge to shape the presence of fatalism among Black males
[16]. Angst is defined as profound existential feeling of fear, dread, despair, and
hopelessness about the challenges of life in the present and thoughts about the future [16].
Whereas, nihilism is defined as the experience of coping with feelings associated with
meaninglessness, hopelessness, and despair [16]. However, while neither of these factors
can be viewed as causing fatalism, they are essential to understanding the presence of
fatalism among some Black males [16].
In a cross-sectional quantitative survey study of 2,864 multiethnic Black male participants in
Florida, Odedina and colleagues [17] found that CaP fatalism was different by ethnic
groups. United States born Black males reported less cancer fatalism compared to
Caribbean-born Black males. However, the authors did not report mean differences in
cancer fatalism by nativity. Therefore, with the limited studies on CaP fatalism, more
research is needed to clarify the impact of cultural beliefs such as cancer fatalism on prostate
cancer prevention and early detection [17].
Prostate Cancer Burden and with-Group Difference Among Black Males
Within-group differences among Black males as it relates to CaP burden and risk factors are
a research area that has been over-looked and under-studied [18]. Further, although the
United States Census routinely refers to all Black males as “African–American” males;
however, Black males are increasingly becoming a heterogeneous group that includes men
who are either English-speaking Caribbean or African men from the continent of Africa
[19]. Further, disparities in the incidence and outcomes of CaP are characteristic of the
global pattern of CaP, with men of African descent suffering disproportionately from the
disease [20]. Thus, as the percentage of Caribbean-born and African-born Black males in the
United States increases, particularly in metropolitan centers, the factors associated with the
risk of these group developing CaP must be clearly identified to better understand and
address CaP disparities among Black males [19]. In addition, U.S.-born and Caribbean-born
Black males have a higher risk of developing, and are more likely to die from CaP; however,
it is not clear whether this knowledge is incorporated into assessments of the benefits and
harms of screening and treatment as perceived by the target population [21].
Gonzalez and colleagues [22] investigated racial and ethnic barriers to PSA screening in
White, U.S.-born Black, and Caribbean-born Black males, paying special attention to the
initiation of PSA screening and continuity with annual testing. White males had undergone
the greatest number of PSA tests, had the lowest frequency of never having undergone a
PSA test, and the highest frequency of annual testing [22]. In comparison, Black males had
the highest frequency of never having been tested [22]. The authors assert that while
Caribbean-born Black males are not less likely than White males to undergo initial PSA
screening. However, they are much less likely to continue with annual PSA testing.
Few studies have examined the differences between U.S.-born and Caribbean-born Black
males relative to CaP. In addition, limited studies have explored the association between
CaP fatalism and screening behavior. The purpose of this study was to compare perceptions
of CaP fatalism and predictors of CaP screening with Prostate Specific Antigen (PSA)
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testing between U.S.-born and Caribbean-born African-American males. The research
questions for this study were as follow: (1) What are the associations between nativity,
perceptions of CaP fatalism, and CaP screening with PSA testing within the last year? (2)
What are the strongest predictors of PSA testing within the last year and do these predictors
vary by perceptions of CaP fatalism and nativity?
Theoretical Framework
The Powe Fatalism Model (PFM) provided the conceptual quantitative framework for this
study. The PFM was originally developed to explain factors associated with individual’s
decision to participate in fecal occult blood testing for colorectal cancer [23]. The PFM
propose that an individual will participate in cancer screening depending on the likelihood of
intervening variables, such as knowledge of cancer, perceptions of cancer fatalism, and
general demographic influences such as race, age, gender, education, and income [23].
The original PFM was modified for this study by retaining the general influences,
intervening variables, and outcome subscales. However, the general influences subscale was
modified to include personal factors (e.g. nativity, age, general health, income, education,
marital status, and health care access) and acculturation (e.g. the process of learning that
occurs when individuals from a different cultural background are exposed to a prolonged,
continuous, first-hand contact with a new culture) [24].
Methods
Data Collection
Primary data was collected from senior centers, community/faith organizations, and health
fairs between January 2012 to March 2012, in Palm Beach, Broward, and Miami-Dade
Counties—South Florida. The Institutional Review Board at Howard University approved
the research protocol. Details of the procedures, risk, and benefit of the study were presented
to each participant at the time consent was obtained. The study questionnaire, institutional
review board approval, and recruitment flyer/letter were mailed to directors of senior
centers, pastors, community/faith sponsors of health fairs, barbershops, and other
predominantly African-American and Caribbean organizations in South Florida, to recruit
potential participants, and provide onsite space for data collection.
Caribbean-born and U.S.-born Black males who self-identified as English speaking between
the ages of 39–75 years old were included in this study. The age inclusion requirement was
based The American Urological Association prostate-specific antigen screening 2009 best
practice, and The American Cancer Society 2009 CaP screening recommendation. However,
males less than 40 years old were included in this study, to document demographic
characteristics of pre-prostate cancer screening males. Participants were selected based on
the study inclusion/exclusion criteria, and provided a $15 gift card for completing the study
questionnaire.
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The Personal Integrative Model of Prostate Cancer Disparity (PIPCaD) Survey [18] and The
Powe Fatalism Inventory [23] were adapted and modified for this study. The development of
the PIPCaD Survey has been described previously [18]. Modifying the original PIPCaD
Survey, was conducted by retaining the CaP early detection behavior, attitude towards CaP
detection and prevention, knowledge of CaP, and acculturation subscales, and adding a
perception of CaP treatment subscale, as defined as, the degree to which respondents
perceived some treatments for CaP can make it harder for men to control their urine, and can
cause problems with a man’s ability to have sex [25]. This variable was assessed with two
items, using a 5-point Likert-type scale anchored by (1) strongly disagree and (5) strongly
agree.
The Powe Fatalism Inventory is a 15-item questionnaire based on the Powe Fatalism Model.
The questions were designed to assess the following four attributes of fatalism (1)
inevitability of death, (2) pessimism, (3) fear, and (4) predetermination [23]. The Powe
Fatalism Inventory was modified from a binary scale (yes or no) to a 5-point Likert-type
scale anchored by (1) strongly disagree to (5) strongly agree.
Analyses
Demographic characteristics were summarized in proportion and means. The reliability of
the modified Powe Fatalism Inventory, and the modified PIPCaD Survey were evaluated by
calculating Cronbach’s Alpha coefficients. CaP knowledge, acculturation, CaP fatalism,
spirituality, and perceptions of CaP treatments scores were summed from the modified Powe
Fatalism Inventory, and the modified PIPCaD Survey for each participant.
Independent sample t tests were conducted to compare CaP knowledge scores, perception of
CaP treatment and fatalism scores of U.S.-born and Caribbean-born African-American
males. Multivariate logistic regression models were constructed to examine statistically
significant predictors of CaP screening with PSA testing within the last year between U.S.-
born and Caribbean-born Black males after adjusting for confounding variables. Data
analyses were conducted using statistical package SPSS 19 (International Business Machine
Corp., Armonk, New York).
Results
A total of 211 males participated in the study (Table 1). Of the 211 participants, 117 (56 %)
were U.S.-born Black males and 94 (44 %) were Caribbean-born Black males. A total of 97
(84 %) U.S-born Black males compared to 74 (81 %) Caribbean-born Black males reported
having public or private health insurance. Fifty (43 %) U.S.-born Black males compared to
34 (37 %) Caribbean-born Black males were recommended CaP screening with PSA testing
within the last year.
Perceptions of CaP Fatalism
CaP fatalism scores are reported in Table 2. Caribbean-born Black males reported higher
CaP fatalism scores compared to U.S.-born Black males, 35.78 (SD = 10.43) versus 32.30
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(SD = 11.10), respectively, p < 0.02. However, U.S-born Black males reported higher
spirituality, perception of CaP treatment, and knowledge scores (e.g. 13.38 (SD = 2.65);
7.37 (SD = 1.86); and 5.51 (SD = 1.86), respectively, p > 0.05), compared to Caribbean-
born Black males (e.g. 13.06 (SD = 2.63); 7.11 (SD = 1.50); 5.27 (SD = 2.01), respectively,
p > 0.05).
Reliability Estimates of the Modified Powe Fatalism Inventory and the Modified PIPCaD
Survey
The reliability estimates of the modified Powe Fatalism Inventory and the modified PIPCaD
Survey are reported in Table 3. The Cronbach’s alpha for the CaP fatalism scale was 0.91.
The reliability estimates for the acculturation scale was 0.49, the spirituality scale was 0.87,
and the perception of CaP treatment scale was 0.73.
Adjusted Predictors of CaP Screening with PSA Testing
The results of the multivariate logistic regression are presented in Table 4. Age, education,
spirituality, access to public or private health insurance, and doctors’ recommendation of
CaP screening with PSA testing were statistical significant predictors of CaP screening with
PSA within the last year. Of significant predictors, U.S.-born and Caribbean-born Black
males with low spirituality scores were less likely to screen for CaP with PSA testing within
the last year (OR = 0.17, 95 % CI = 0.06, 0.54, p < 0.05) compared to males with high
spirituality scores. Further, compared to U.S.-born and Caribbean-born Black males without
a doctors’ recommendation of CaP screening with PSA testing, males with a doctors’
recommendation were more likely to screen for CaP with PSA testing within the last year
(OR = 14.76, 95 % CI = 4.59, 47.41, p < 0.05).
However, nativity, acculturation, CaP fatalism, and CaP knowledge were not statistically
significant in predicting of CaP screening with PSA testing within the last year (OR = 0.80,
95 % CI = 0.26, 2.48, p = 0.70; OR = 1.27, 95 % CI = 0.46, 3.49; OR = 1.37, 95 % CI =
0.48, 3.91; OR = 0.59, 95 % CI = 0.20, 1.79, p > 0.05 respectively).
Discussion
This study has several important findings. First, the modified Powe Fatalism Inventory and
the Personal Integrative Model of Prostate Cancer Disparity Survey was found to be reliable
in measuring study variables. The internal consistency of modified Powe Fatalism
Inventory, and the modified PIPCaD survey was similar to other large primary data
collection studies. The Cronbach’s alpha for the CaP fatalism scale in the current study was
0.91 (Table 3). Powe [23] found in analyses of a sample of 192 (61 % Blacks and 78 %
females) participants Cronbach’s alpha ranging from 0.84 to 0.89, for the Powe Fatalism
Inventory. In another primary data collection study, Odedina and colleagues [18] evaluated
of the PIPCaD survey in a sample of 3,400 males. The study was conducted to investigate
CaP differences among (1) U.S.-born, (2) African-born, and (3) Caribbean-born Black males
concerning CaP risk reduction and early detection behaviors. The authors reported
Cronbach’s alpha for the PIPCaD survey variables ranging from 0.71 to 0.94 [18].
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Second, the current study did not find a statistically significant difference in CaP knowledge
and nativity (5.52 vs. 5.27 for U.S.-born and Caribbean-born Black males, t = 0.88; df =
206; p = 0.38). Magnus [19] also reported no significant differences in CaP knowledge
levels by nativity. The mean CaP knowledge for U.S.-born Black, English-speaking
Caribbean, Haitian-American, and African men was 71.2, 69.9, 66.4, and 63.0, respectively
[19]. However, Magnus noted two main study limitations. First, the convenience sample of
the study may not be representative of the population of Black males in the United States,
and the results may not be generalized to all Black males. Second, only the face validity of
the questionnaire was evaluated and more extensive reliability and validity assessments of
the instrument were not undertaken. The current study improved on the research methods
and design used by Magnus [19] by incorporating the Powe Fatalism Model as the
conceptual framework for the development of the survey instrument, and an extensive
reliability and validity assessments of the current study instrument was conducted.
Third, in the current study, U.S.-born and Caribbean-born Black males had a statistically
difference in CaP fatalism scores. This was similar to the finding reported by Odedina and
colleagues [17] who found U.S.-born Black males reported less cancer fatalism compared to
Caribbean-born Black males. In another study, Powe [23] reported that there was a
prevailing fatalistic attitude among the sample as indicated by the fatalism scores. In
particular, the mean fatalism score for the sample was 10.0 out of a possible maximum score
of 15 indicating a high degree of fatalism. Blacks had a mean fatalism score above the mean
(x = 10.9); whereas, in contrast, White participants had a mean fatalism score below the
sample mean (x = 8.8) [23]. Further, this difference was significantly significant t(105.1) =
4.3, p = 0.001 [23]. However, this study compared Black to White participants, and the
study had a very small sample of Black males.
Fourth, in terms of CaP screening with PSA testing within the last year; age, education,
spirituality, access to public or private health insurance were statistical significant predictors
but CaP fatalism and knowledge of CaP were not. Further, doctors’ recommendation of CaP
screening with PSA testing within the last year was the strongest predictor of CaP screening
with PSA. Gonzalez and colleagues [22] in a study of U.S.-born Black and Caribbean-born
Black males, also found males without physician involvement, compared to males with
physician involvement were less likely to screen for CaP annually. However, the authors
noted that because their data was correlational, the issue of causality remains unclear.
Study Limitations
Several study limitations may have affected the interpretation of the study results. First, a
cross-sectional research design was used to investigate the main outcome. Therefore, the
research design may not reflect causation. Second, a non-probability sample was utilized in
this study and therefore may not be representative of U.S.-born and Caribbean-born Black
males in South Florida. Third, participants self identified as U.S.-born and Caribbean-born
Black males. It is possible that some males who were born in the United State to Caribbean
parents may have been included in the sample as U.S.-born without taking into account the
interaction of the parent’s nativity. Fourth, because data on screening was assessed
retrospectively, it possible that error in recall may have impacted reporting of PSA screening
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within the last year. Finally, a total of 227 participants completed the quantitative survey
instrument; one male who self-identified as African-born was excluded from data analyses
and 15 males were also excluded from data analyses because of missing responses.
New Contribution to the Literature
This study provides important implications for future research in the area of CaP fatalism,
nativity, and providers’ recommendation of CaP screening. Given, the recent controversy in
CaP screening recommendation and the inconsistency in recommendations for CaP
screening, males were more likely to screen for CaP if they received screening
recommendations. Therefore, balancing the need to reduce over-treatment, over-diagnosis,
and mortality with the consistency of CaP screening recommendations will continue to be
critical.
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Table 1










 Less than high school 6 (5.3) 18 (19.4)
 High school degree 23 (24.8) 22 (23.7)
 Some college training 27 (23.9) 21 (22.6)
 College degree 29 (25.7) 25 (26.9)
 Postgraduate 23 (20.4) 7 (7.5)
Income
 $0–$19,999 16 (14.3) 18 (21.2)
 $20,000–$39,999 27 (24.1) 21 (24.7)
 $40,000–$59,999 18 (16.1) 22 (25.9)
 $60,000–$79,999 14 (12.5) 8 (9.4)
 $80,000–$99,999 12 (10.7) 11 (12.9)
 $100,000 or above 25 (22.3) 5 (5.9)
Age
 Less than 40 years 21 (18.6) 16 (17.2)
 40–49 years 17 (15.0) 28 (30.1)
 50–59 years 28 (24.8) 24 (25.8)
 60–69 years 29 (25.7) 22 (23.7)
 70–79 years 18 (15.9) 3 (3.2)
General health
 Excellent 17 (15.2) 14 (15.2)
 Very good 42 (37.5) 31 (33.7)
 Good 33 (29.5) 25 (27.2)
 Fair 20 (17.9) 22 (23.9)
Marital status
 Single 26 (22.8) 19 (20.7)
 Married 74 (64.9) 63 (68.5)
 Divorced 9 (7.9) 6 (6.5)
 Widowed 5 (4.4) 4 (4.3)
Employment status
 Full-time 59 (52.7) 71 (78.0)
 Part-time 8 (7.1) 4 (4.4)
 Retired 39 (34.8) 11 (12.1)
 Unemployed 6 (5.4) 5 (5.5)
Public or private health insurance
 No 19 (16.4) 17 (18.7)
 Yes 97 (83.6) 74 (81.3)
































 Low 68 (65.4) 36 (34.6)
 High 18 (47.4) 20 (52.6)
Prostate cancer knowledge
 Low 53 (56.4) 41 (43.6)
 High 61 (54.5) 51 (45.5)
Spirituality
 Low 47 (48.5) 50 (51.5)
 High 68 (54.5) 44 (39.3)
Acculturation
 Low 64 (57.1) 48 (42.9)
 High 51 (54.3) 43 (45.7)
Regular physician
 No 18 (15.4) 14 (15.2)
 Yes 99 (84.6) 78 (84.8)
Doctor recommended prostate cancer screening with prostate specific
 antigen (PSA) within the last year
 No 66 (56.9) 59 (63.4)
 Yes 50 (43.1) 34 (36.6)
Where were participants given the survey?
 Fort Lauderdale barbershops 6 (5.1) 16 (17.0)
 Fort Lauderdale churches 5 (4.3) 37 (39.4)
 Miami churches 69 (59.0) 24 (20.5)
 Palm Beach churches 24 (20.5) 0 (0.0)
 Prostate cancer events 3 (2.6) 7 (7.4)
 Community or social events 9 (7.7) 24 (25.5)
 Other 1 (0.9) 3 (3.2)
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Table 2
Prostate cancer fatalism, acculturation, spirituality, perceptions of prostate cancer treatments, and knowledge
scores (n = 211)
Variables U.S.-born Black
males n = 117
mean (SD)
Caribbean-born




Prostate cancer fatalism score 32.30 (11.10) 35.78 (10.43) 0.02*
Acculturation score 14.87 (2.75) 15.20 (2.78) 0.40
Spirituality score 13.38 (2.65) 13.06 (2.63) 0.28
Perception of prostate cancer treatment score 7.37 (1.86) 7.11 (1.50) 0.38
Prostate cancer knowledge score 5.51 (1.86) 5.27 (2.01) 0.38
a
Independent sample t test
*
p < 0.05
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Table 3
Reliability estimates of the modified powe inventory and the modified personal integrative model of prostate















Prostate cancer fatalism 0.84–0.89 192 0.91
Acculturation 0.71 3,400 0.49
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Table 4
Adjusted predictors of prostate cancer screening with prostate specific antigen (PSA) test within the last year
(n = 211)
Variables Adjusted odds
ratio (95 % CI)
Nativity
 Caribbean-born 0.80 (0.26, 2.48)
 U.S.-born 1 (reference)
Age
 Less than 40 years 0.04 (0.004, 0.42)*
 40–49 years 1.19 (0.29, 4.93)
 50–59 years 1 (reference)
 60–69 years 1.87 (0.40, 8.75)
 70–79 years 0.20 (0.02, 2.22)
General health
 Excellent 1.33 (0.30, 5.88)
 Very good 1 (reference)
 Good 1.13 (0.27, 4.71)
 Fair 0.26 (0.06, 1.15)
Income
 $0–$19,999 0.58 (0.08, 4.29)
 $20,000–$39,999 1 (reference)
 $40,000–$59,999 0.29 (0.06, 1.45)
 $60,000–$79,999 1.52 (0.27, 8.70)
 $80,000–$99,999 2.05 (0.32, 13.02)
 $100,000 or above 0.73 (0.10, 5.30)
Education
 Less than high school 0.07 (0.007, 0.72)*
 High school degree 0.45 (0.10, 2.09)
 Some college training 0.73 (0.18, 2.94)
 College degree 1 (reference)
 Postgraduate 0.42 (0.08, 2.16)
Marital status
 Single 1.52 (0.37, 6.30)
 Married 1 (reference)
 Divorced 1.62 (0.21, 12.50)
 Widowed 0.04 (0.00, 1.24)
Prostate cancer fatalism
 Low 1 (reference)
 High 1.37 (0.48, 3.91)
 Perception of prostate cancer treatment
 Low 1 (reference)
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Variables Adjusted odds
ratio (95 % CI)
 High 1.51 (0.53, 4.34)
Prostate cancer knowledge
 Low 0.59 (0.20, 1.79)
 High 1 (reference)
Spirituality
 Low 0.17 (0.06, 0.54)*
 High 1 (reference)
Acculturation
 Low 1 (reference)
 High 1.27 (0.46, 3.49)
Public or private health insurance
 No 0.07 (0.007, 0.66)*
 Yes 1 (reference)
Regular Physician
 No 0.64 (0.05, 8.36)
 Yes 1 (reference)
Doctor recommended prostate cancer screening with prostate
 specific antigen (PSA) test within the last year
 No 1 (reference)
 Yes 14.76 (4.59, 47.41)*
*
p < 0.05
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